A follicular malignant lymphoma of a large cell, also known simply as FLCL (follicular large cell lymphoma), is a rare form of non-Hodgkin’s lymphoma. This type of cancer is highly responsive to revolutionary cancer therapy, such as monoclonal antibodies, which help reduce the many risks associated with conventional chemotherapy because it targets particular markers found in tumour cells. The antibodies also help destroy the tumour by stimulating the production of more immune cells.
Cancer treatment using monoclonal antibodies is one of the most advanced therapies used for the management of malignant tumours. The treatment is highly advanced with doctors choosing antibodies that are specifically designed to target certain antigens in cancer cells. To date, it is considered as one of the most successful therapeutic methods to fight cancer. Given the large-scale and cutting edge technology it requires, the treatment is only found in select countries.
Thankfully, some countries in Southeast Asia have been heavily investing in their medical infrastructure. These countries, namely Thailand, Singapore, and Malaysia, already have the necessary equipment and technology to treat patients diagnosed with follicular large cell lymphoma using revolutionary monoclonal antibody therapy. And with a large number of hospitals, cancer centres, and cancer specialists on board, patients do not have to wait a long time to receive the treatment they need.
The availability of advanced medical therapies, the dedication of highly esteemed cancer specialists, and the shorter waiting period are some of the top reasons why travelling to Southeast Asia for treatment is the best option for cancer patients. On top of these, patients can now access new cancer therapies more easily, thanks to the lower cost of treatment and faster entry procedures offered by Southeast Asia’s medical tourism hubs.
Some of the top options for patients seeking treatment for follicular malignant lymphoma in Southeast Asia are Gleneagles Hospital in Kuala Lumpur, Changi General Hospital in Singapore, and Bangkok Hospital Medical Center in Bangkok. All these are Joint Commission International (JCI)-accredited and are fully equipped to treat all forms of lymphoma.